echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Colloids and Surfaces B: MTX+HCQ nanomicelles are three times more effective than traditional drug delivery methods

    Colloids and Surfaces B: MTX+HCQ nanomicelles are three times more effective than traditional drug delivery methods

    • Last Update: 2021-08-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease, affecting nearly 1% of the world's population
    .


    Current treatments for RA aim to achieve prolonged active periods and early and sustained remission of the disease through the gradual use of different drugs


    Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease, affecting nearly 1% of the world's population


    In a study in Brazil, a new type of hydroxychloroquine and methotrexate co-loaded with Pluronic® F-127 nanomicelles was developed and its therapeutic effect on RA was evaluated


    In this study, the researchers newly developed a new type of Pluronic® F-127 nanomicelles, the micelles are loaded with new hydroxychloroquine and methotrexate
    .


    Research results show that this drug-loaded nanomicelle can regulate the inflammatory process of RA and reduce osteoclast production, edema and cell migration to joints


    In this study, the researchers newly developed a new type of Pluronic® F-127 nanomicelles, the micelles are loaded with new hydroxychloroquine and methotrexate


    Nanomicelles are one of the most widely used nanoparticles, which can improve the blood circulation time, bioavailability and specificity of drugs
    .


    The therapeutic agent can be transported passively or actively after systemic administration, and selectively accumulate in the inflammation site.


    Nanomicelles are one of the most widely used nanoparticles, which can improve the blood circulation time, bioavailability and specificity of drugs


    Experimental contentExperimental content

    Thirty-five C57BL/6 mice were divided into 7 experimental groups, each consisting of 5 animals
    .

    Thirty-five C57BL/6 mice were divided into 7 experimental groups, each consisting of 5 animals
    .


    Animal handling

    Animal handling animal handling

    Sham : 0.
    1 mL saline and 0.
    1 mL Freund's complete adjuvant

    Sham : 0.
    1 mL saline and 0.
    1 mL Freund's complete adjuvant Sham

    Saline:Equivalent normal saline

    Saline:Equivalent saline Saline

    mBSA: 500 μg methylated bovine serum albumin (mBSA), 0.
    1 mL saline and 0.
    1 mL Freund’s complete adjuvant
    .

    mBSA: 500 μg methylated bovine serum albumin (mBSA), 0.
    1 mL saline and 0.
    1 mL Freund’s complete adjuvant
    .


    mBSA:

    Pluronic : 127-Pluronic

    Pluronic : 127-Pluronic Pluronic

    intervention group 1 : 127-Pluronic−HCQ-MTX nanomicelles (2 mg / K and 1 mg / Kg, respectively);

    intervention group 1 : 127-Pluronic−HCQ-MTX nanomicelles (2 mg / K and 1 mg / Kg, respectively); intervention group 1

    intervention group 2: 127-Pluronic−HCQ-MTX nanomicelles (1 mg / K and 0.
    5 mg / Kg, respectively).

    intervention group 2: 127-Pluronic−HCQ-MTX nanomicelles (1 mg / K and 0.
    5 mg / Kg, respectively).
    intervention group 2:

    Experimental results

    Experimental results Experimental results
    • In vitro drug release experiment:
  • In vitro drug release experiment:
  • In vitro drug release test: In vitro drug release test:

    • Osteoclastogenesis experiment
  • Osteoclastogenesis experiment
  • Osteoclast production experiment Osteoclast production experiment

    Expose monocytes in human peripheral blood to nanomicelles formed by the combination of two different concentrations of methotrexate and hydroxychloroquine (127-Pluronic-HCQ-MTX nanomicelles), 20 ug/mL HCQ and 074 ng/mL MTX and 70 ug/mL HCQ and 2.
    6 ng/mL MTX
    .


    Four dilutions of nanomicelles (1:10, 1:100, 1:1000, and 1:2000) were tested in order to study a more effective concentration for RA treatment


    Expose monocytes in human peripheral blood to nanomicelles formed by the combination of two different concentrations of methotrexate and hydroxychloroquine (127-Pluronic-HCQ-MTX nanomicelles), 20 ug/mL HCQ and 074 ng/mL MTX and 70 ug/mL HCQ and 2.


    The results showed that the inhibition rate of MRP1 was 40-50%, proving that nanomicelles can improve the accumulation of drugs in cells


    HCQ and MTX combined treatment of RA, compared with the current traditional way of administration, the lower dose of nanomicelle administration shows a better anti-inflammatory effect, and can be less drug-resistant
    .

    Original source: Tais Monteiro Magne, Edward Helal-Neto, Luana Barbosa Correa, et al.
    Rheumatoid arthritis treatment using hydroxychloroquine and methotrexate co-loaded nanomicelles: In vivo results, Colloids and Surfaces B: Biointerfaces,
    Volume 206,2021,111952,https ://doi.
    org/10.
    1016/j.
    colsurfb.
    2021.
    111952.

    Original source: Tais Monteiro Magne, Edward Helal-Neto, Luana Barbosa Correa, et al.
    Rheumatoid arthritis treatment using hydroxychloroquine and methotrexate co-loaded nanomicelles: In vivo results, Colloids and Surfaces B: Biointerfaces, et al.

    Volume 206,2021, 111952, https://doi.
    org/10.
    1016/j.
    colsurfb.
    2021.
    111952.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.